IL223248A0 - Method for evaluation of sensitivity of cancer-tissue-derived cell mass or aggregated cancer cell mass to drug or radioactive ray - Google Patents

Method for evaluation of sensitivity of cancer-tissue-derived cell mass or aggregated cancer cell mass to drug or radioactive ray

Info

Publication number
IL223248A0
IL223248A0 IL223248A IL22324812A IL223248A0 IL 223248 A0 IL223248 A0 IL 223248A0 IL 223248 A IL223248 A IL 223248A IL 22324812 A IL22324812 A IL 22324812A IL 223248 A0 IL223248 A0 IL 223248A0
Authority
IL
Israel
Prior art keywords
cell mass
cancer
sensitivity
drug
tissue
Prior art date
Application number
IL223248A
Original Assignee
Renaissance Energy Invest Co Ltd
Osaka Prefectural Hospital Organization
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2010120827A external-priority patent/JP5809782B2/en
Application filed by Renaissance Energy Invest Co Ltd, Osaka Prefectural Hospital Organization filed Critical Renaissance Energy Invest Co Ltd
Publication of IL223248A0 publication Critical patent/IL223248A0/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL223248A 2010-05-26 2012-11-26 Method for evaluation of sensitivity of cancer-tissue-derived cell mass or aggregated cancer cell mass to drug or radioactive ray IL223248A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010120827A JP5809782B2 (en) 2009-12-24 2010-05-26 Method for evaluating drug or radiosensitivity of cancer tissue-derived cell mass or cancer cell aggregate
PCT/JP2011/062075 WO2011149013A1 (en) 2010-05-26 2011-05-26 Method for evaluation of sensitivity of cancer-tissue-derived cell mass or aggregated cancer cell mass to medicinal agent or radioactive ray

Publications (1)

Publication Number Publication Date
IL223248A0 true IL223248A0 (en) 2013-02-03

Family

ID=45015754

Family Applications (1)

Application Number Title Priority Date Filing Date
IL223248A IL223248A0 (en) 2010-05-26 2012-11-26 Method for evaluation of sensitivity of cancer-tissue-derived cell mass or aggregated cancer cell mass to drug or radioactive ray

Country Status (3)

Country Link
KR (1) KR20130024904A (en)
IL (1) IL223248A0 (en)
WO (1) WO2011149013A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104011197B (en) * 2011-12-19 2016-08-24 雅马哈发动机株式会社 Object sorting unit and object method for separating
US20140341680A1 (en) * 2011-12-20 2014-11-20 Yamaha Hatsudoki Kabushiki Kaisha Object selecting device and object selecting method
KR101674468B1 (en) * 2013-05-07 2016-11-10 재단법인 아산사회복지재단 Methods for cultivation of patient derived primary cultured turmor cell (PCC) and patient-derived tumor xenograft (PDX) animal model produced by using PCC
JP2017205021A (en) * 2014-09-26 2017-11-24 Jsr株式会社 Method for preparing spheroid of primary cancer cell, spheroid, screening method, and diagnostic method
JP2016136848A (en) * 2015-01-26 2016-08-04 富士フイルム株式会社 Chemical evaluating method and chemical screening method
WO2018169007A1 (en) * 2017-03-16 2018-09-20 株式会社Ｌｓｉメディエンス Three-dimensional culture of primary cancer cells using tumor tissue
CA3079134A1 (en) * 2017-10-31 2019-05-09 Cemm-Forschungszentrum Fur Molekulare Modezin Gmbh Methods for determining selectivity of test compounds
JP7197203B2 (en) * 2018-05-30 2022-12-27 国立大学法人大阪大学 Methods of screening for substances that affect the formation, structure or function of human blood vessels, and methods of manufacturing human blood vessels
WO2023096065A1 (en) * 2021-11-24 2023-06-01 엠비디 주식회사 Method for diagnosing radiation sensitivity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5652809B2 (en) * 2009-03-02 2015-01-14 株式会社ルネッサンス・エナジー・インベストメント Cancer tissue-derived cell mass and preparation method thereof
JP2011115106A (en) * 2009-12-04 2011-06-16 Rei Medical Co Ltd Cancer cell aggregate and method for preparing the same

Also Published As

Publication number Publication date
WO2011149013A1 (en) 2011-12-01
KR20130024904A (en) 2013-03-08

Similar Documents

Publication Publication Date Title
IL223248A0 (en) Method for evaluation of sensitivity of cancer-tissue-derived cell mass or aggregated cancer cell mass to drug or radioactive ray
GB2484621B (en) Gamma ray detectors having azimuthal sensitivity
GB2506060B (en) Apparatuses and methods for detection of radiation including neutrons and gamma rays
EP2703843A4 (en) Calibration device for photon counting radiation detector and calibration method thereof
GB2499709B (en) Lithium based scintillators for neutron detection
EP2539697A4 (en) A high-energy x-ray spectroscopy-based inspection system and methods to determine the atomic number of materials
EP2783204A4 (en) X-ray distance indicator and related methods
EP2618154A4 (en) Method for determining effectiveness of medicine containing antibody as component
EP2795371A4 (en) Neutron detection using a shielded gamma detector
EP2603926A4 (en) Charged particle detector
HK1172092A1 (en) Gamma camera and method for detecting radiation ray by utilizing same
HK1214364A1 (en) Cell analysis by mass cytometry
ZA201207895B (en) Method of calibrating excore detectors in a nuclear reactor
EP2700980A4 (en) Neutron detector coated with boron and method for manufacture thereof
GB201107076D0 (en) Neutron detector
GB201410896D0 (en) Detector and method for simultaneously detecting gamma ray and neutron ray using same
EP2967465A4 (en) System for the detection of gamma radiation from a radioactive analyte
GB2494794B (en) Radioactive/nuclear threat monitoring using long detectors
EP2565682A4 (en) Scintillator for neutrons and neutron detector
IL237286A0 (en) Energy-sensitive fast neutron imaging detector and method for energy-sensitive fast neutron detection
GB2506320B (en) Measurement of formation porosity using a single gamma ray detector
GB2494231B (en) On-chip radiation dosimeter background
EP2569654A4 (en) Neutron detectors for active interrogation
GB201413128D0 (en) Method and decive for measuring effective atomic number of object
GB201110371D0 (en) Materials and methods for determining sensitivity potential of compounds